News for Healthier Living
New Drug to Prevent Migraine May Start Working Right Away
A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology(r), the medical journal of the American Academy of Neurology. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist taken by mouth.
December 23, 2024
January 1 2025December 31 2024December 30 2024December 29 2024December 28 2024December 27 2024December 26 2024December 24 2024December 23 2024December 21 2024December 20 2024December 19 2024
|
|
|
|
|